Patient Care and General Interest
The Boston Marathon race director, who has run the marathon 46 straight times, underwent triple bypass surgery last Friday at Boston’s Massachusetts General Hospital.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung - Cancer
October 11, 2018
This analysis of the National Cancer Database included over 2000 eligible patients resected with N2 disease who did not receive induction therapy. The addition of radiotherapy to postoperative chemotherapy did not affect survival in either the unmatched or the matched groups.
October 8, 2018
This video demonstrates a posterolateral thoracotomy. The authors detail the procedure in a step-by-step fashion, using diagrams and surgical video to illustrate key technical elements.
October 3, 2018
This video demonstrates a robotic right upper lobe posterior segmentectomy using indocyanine green guidance for a 73-year-old female who had had a previous left lower lobectomy.
September 26, 2018
This video demonstrates a robotic right upper lobe apical segmentectomy with a three-arm technique and a 10 mm assistant port as surgical treatment for a lung metastasis from colorectal carcinoma.
September 26, 2018
Using the National Cancer Database, the effect of the timing of computed tomography (CT) surveillance after resection of non-small cell lung cancer on survival was investigated. Survival was similar for patients undergoing CTs every three months or every six months compared to those undergoing annual surveillance CTs. More frequent imaging also had
September 26, 2018
Data in the STS Database indicate that invasive mediastinal staging is underused in patients undergoing resection for non-small cell lung cancer, and that the pattern of use varies widely among the participants. Use of guidelines outlining indications for invasive mediastinal staging should be encouraged.
September 25, 2018
A seismic shift occurred today when the NELSON screening trial results were presented at the IASLC 19th World Conference on Lung Cancer (
September 25, 2018
This comprises the eagerly anticipated summary of the second primary endpoint of the PACIFIC trial of Durvalumab vs placebo in patients who completed CT/RT without progression for unresectable stage III NSCLC. Durvalumab significantly improved overall survival, progression free survival, and time to distant metastasis or death.
September 21, 2018
Patient Care and General Interest
A man who received quintuple bypass surgery in Little Rock, Arkansas, USA, plans to cycle a 50-mile race only two months later.